Rapamycin has become the darling of anti-ageing enthusiasts, having been shown to prolong the life of worms and mice. It's given to transplant patients to prevent graft rejection, but now scientists believe it could also slow ovary ageing, thus delaying the menopause and extending fertility.


It's early days for the Validating Benefits of Rapamycin for Reproductive Ageing Treatment study, but preliminary results suggest that it could decrease ovary ageing by 20 percent without women experiencing the drug's many reported side effects, including nausea and high blood pressure.